BMI: Q2 sales declined year-over-year but improved sequentially, with flat 2026 revenue outlook reaffirmed
Q2 2026 saw a 7% year-over-year sales decline but a 9% sequential increase, with improved order rates and project ramp-ups. Margins and EPS declined, but management reaffirmed flat organic revenue guidance for 2026 and highlighted strong long-term demand drivers and disciplined capital allocation.B…